L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.88 NOK 0.88% Market Closed
Market Cap: 341.3m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Net Margin
Lytix Biopharma AS

-2 202.4%
Current
-28 773%
Average
-7.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2 202.4%
=
Net Income
-87.9m
/
Revenue
4m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
NO
Lytix Biopharma AS
OSE:LYTIX
341.3m NOK
-2 202%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-21 040%
US
Abbvie Inc
NYSE:ABBV
301B USD
9%
US
Amgen Inc
NASDAQ:AMGN
162B USD
13%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.5B USD
-5%
US
Gilead Sciences Inc
NASDAQ:GILD
115.4B USD
0%
US
Epizyme Inc
F:EPE
94.1B EUR
-392%
AU
CSL Ltd
ASX:CSL
138B AUD
18%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.6B USD
34%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
34.1B EUR
-14%
Country NO
Market Cap 341.3m NOK
Net Margin
-2 202%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 301B USD
Net Margin
9%
Country US
Market Cap 162B USD
Net Margin
13%
Country US
Market Cap 127.5B USD
Net Margin
-5%
Country US
Market Cap 115.4B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 138B AUD
Net Margin
18%
Country US
Market Cap 88.6B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 34.1B EUR
Net Margin
-14%

Profitability Report

View the profitability report to see the full profitability analysis for Lytix Biopharma AS.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2 202.4%
=
Net Income
-87.9m
/
Revenue
4m
What is the Net Margin of Lytix Biopharma AS?

Based on Lytix Biopharma AS's most recent financial statements, the company has Net Margin of -2 202.4%.